{"id":"https://openalex.org/W7162640468","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.e16500","title":"In silico phase III clinical trial of avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma using a machine learning model transfer approach.","display_name":"In silico phase III clinical trial of avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma using a machine learning model transfer approach.","alternate_titles":[],"publication_year":2026,"publication_date":"2026-05-28","ids":{"openalex":"https://openalex.org/W7162640468","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.e16500"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2026.44.16_suppl.e16500","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.e16500","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.e16500","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2026.44.16_suppl.e16500","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7162640468"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2026.44.16_suppl.e16500","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5137296750","display_name":"Zuhair Majeed","orcid":"https://orcid.org/0009-0003-7674-4436","observed_orcids":["https://orcid.org/0009-0003-7674-4436"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zuhair Majeed","raw_affiliation_strings":["Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH","institution_ids":["https://openalex.org/I2799885155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5137280557","display_name":"Peng Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peng Li","raw_affiliation_strings":["Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH","institution_ids":["https://openalex.org/I2799885155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089486616","display_name":"Claire F. Verschraegen","orcid":"https://orcid.org/0000-0001-6544-3089","observed_orcids":["https://orcid.org/0000-0001-6544-3089"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Claire F. Verschraegen","raw_affiliation_strings":["Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH","institution_ids":["https://openalex.org/I2799885155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003245399","display_name":"John L. Hays","orcid":"https://orcid.org/0000-0003-3140-8677","observed_orcids":["https://orcid.org/0000-0003-3140-8677"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John L. Hays","raw_affiliation_strings":["Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, The Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5136150079","display_name":"Khalid Niazi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802841970","display_name":"The Ohio State University Wexner Medical Center","ror":"https://ror.org/00c01js51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Khalid Niazi","raw_affiliation_strings":["Department of Pathology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH","institution_ids":["https://openalex.org/I2802841970","https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014511658","display_name":"Merve Hasanov","orcid":"https://orcid.org/0000-0002-6102-4917","observed_orcids":["https://orcid.org/0000-0002-6102-4917"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Merve Hasanov","raw_affiliation_strings":["Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH","institution_ids":["https://openalex.org/I2799885155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009171545","display_name":"Elshad Hasanov","orcid":"https://orcid.org/0000-0002-7195-0842","observed_orcids":["https://orcid.org/0000-0002-7195-0842"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I4405282248","display_name":"Pelotonia","ror":"https://ror.org/05jcvqz82","country_code":"US","type":"funder","lineage":["https://openalex.org/I4405282248"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elshad Hasanov","raw_affiliation_strings":["Pelotonia Institute for Immuno-Oncology and Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center \u2013 James Cancer Hospital and Solove Research Institute, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pelotonia Institute for Immuno-Oncology and Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center \u2013 James Cancer Hospital and Solove Research Institute, Columbus, OH","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I4405282248"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"44","issue":"16_suppl","first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9164999723434448,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9164999723434448,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.035999998450279236,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12422","display_name":"Radiomics and Machine Learning in Medical Imaging","score":0.01269999984651804,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/avelumab","display_name":"avelumab","score":0.8009999990463257},{"id":"https://openalex.org/keywords/axitinib","display_name":"axitinib","score":1.0},{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":1.0},{"id":"https://openalex.org/keywords/advanced-renal-cell-carcinoma","display_name":"advanced renal cell carcinoma","score":0.9829999804496765},{"id":"https://openalex.org/keywords/in-silico-clinical-trials","display_name":"in silico clinical trials","score":0.7879999876022339},{"id":"https://openalex.org/keywords/model-transfer","display_name":"model transfer","score":0.8220000267028809},{"id":"https://openalex.org/keywords/javelin-renal-101","display_name":"JAVELIN Renal 101","score":0.8659999966621399},{"id":"https://openalex.org/keywords/the-cancer-genome-atlas","display_name":"TCGA","score":0.7649999856948853},{"id":"https://openalex.org/keywords/rna-seq","display_name":"RNA-seq","score":0.6729999780654907},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.5860000252723694},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":1.0},{"id":"https://openalex.org/keywords/restricted-mean-survival-time","display_name":"restricted mean survival time","score":0.7649999856948853},{"id":"https://openalex.org/keywords/rare-disease-drug-development","display_name":"rare disease drug development","score":0.5910000205039978},{"id":"https://openalex.org/keywords/patient-selection","display_name":"patient selection","score":0.671999990940094},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.5},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.3880000114440918}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8137000203132629},{"id":"https://openalex.org/C2776539811","wikidata":"https://www.wikidata.org/wiki/Q4830631","display_name":"Axitinib","level":4,"score":0.6104000210762024},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5856000185012817},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.5307999849319458},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5303000211715698},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.5134000182151794},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4975999891757965},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.47510001063346863},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.4634000062942505},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.45840001106262207},{"id":"https://openalex.org/C108650721","wikidata":"https://www.wikidata.org/wiki/Q1783253","display_name":"Counterfactual thinking","level":2,"score":0.42640000581741333},{"id":"https://openalex.org/C2781068499","wikidata":"https://www.wikidata.org/wiki/Q3242950","display_name":"Kidney cancer","level":3,"score":0.4009999930858612},{"id":"https://openalex.org/C2776820818","wikidata":"https://www.wikidata.org/wiki/Q7699074","display_name":"Temsirolimus","level":5,"score":0.3555000126361847},{"id":"https://openalex.org/C119857082","wikidata":"https://www.wikidata.org/wiki/Q2539","display_name":"Machine learning","level":1,"score":0.33869999647140503},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.31119999289512634},{"id":"https://openalex.org/C2778439243","wikidata":"https://www.wikidata.org/wiki/Q7157043","display_name":"Pazopanib","level":4,"score":0.3093999922275543},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.3057999908924103},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.29440000653266907},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.2921000123023987},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.29190000891685486},{"id":"https://openalex.org/C2777381376","wikidata":"https://www.wikidata.org/wiki/Q21083261","display_name":"Avelumab","level":5,"score":0.2890999913215637},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.28870001435279846},{"id":"https://openalex.org/C160798450","wikidata":"https://www.wikidata.org/wiki/Q4230870","display_name":"Concordance","level":2,"score":0.27059999108314514},{"id":"https://openalex.org/C34626388","wikidata":"https://www.wikidata.org/wiki/Q721129","display_name":"Nomogram","level":2,"score":0.2655999958515167},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.2648000121116638},{"id":"https://openalex.org/C2780227381","wikidata":"https://www.wikidata.org/wiki/Q1357376","display_name":"Nephrectomy","level":3,"score":0.263700008392334},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2581000030040741}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2026.44.16_suppl.e16500","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.e16500","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.e16500","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2026.44.16_suppl.e16500","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1200/jco.2026.44.16_suppl.e16500","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.e16500","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.e16500","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2026.44.16_suppl.e16500","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7162640468.pdf","grobid_xml":"https://content.openalex.org/works/W7162640468.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7169850654","https://openalex.org/W4379341483","https://openalex.org/W4399118467","https://openalex.org/W7162628046","https://openalex.org/W4409821840","https://openalex.org/W4402992294","https://openalex.org/W7157187446","https://openalex.org/W4200203934","https://openalex.org/W3035559648","https://openalex.org/W4414780377"],"abstract_inverted_index":{"e16500":[0],"Background:":[1],"Randomized":[2],"clinical":[3,44],"trials":[4],"(RCTs)":[5],"are":[6,15],"the":[7,39,81,111,146,222,233],"gold":[8],"standard":[9],"for":[10,92,295],"establishing":[11],"treatment":[12,26,192,243],"benefit,":[13],"but":[14,177],"resource-intensive.":[16],"An":[17],"in":[18,71,298],"silico":[19],"virtual":[20],"trial":[21,45],"that":[22],"enables":[23],"exploration":[24],"of":[25,41,263],"effects":[27,123],"from":[28,251],"available":[29,141,147],"data":[30,56,88],"could":[31],"complement":[32],"this":[33,273,291],"process.":[34],"We":[35],"aimed":[36],"to":[37,57,110,114,221,240,255,279],"demonstrate":[38],"feasibility":[40],"an":[42,270],"in-silico":[43,271],"using":[46,86,126],"a":[47,65,155,190,247,276,302],"machine":[48],"learning":[49],"(ML)":[50],"model":[51,234],"transfer":[52,235],"approach,":[53],"leveraging":[54],"RCT":[55,69,85,151],"generate":[58,115],"counterfactual":[59,116,186,242],"outcomes":[60,244],"and":[61,89,95,104,129,245,283],"assess":[62],"whether":[63],"such":[64],"framework":[66,292],"reproduces":[67],"observed":[68],"behavior":[70],"real-world":[72],"TCGA":[73,223],"data.":[74,143],"Methods:":[75],"ML":[76],"models":[77],"were":[78,107,124],"trained":[79],"on":[80,140],"JAVELIN":[82,148],"Renal":[83,149],"101":[84,150],"RNA-seq":[87],"internally":[90],"validated":[91],"overall-survival":[93],"(OS)":[94],"progression-free":[96],"survival":[97,117,132,309],"(PFS)":[98],"within":[99,269],"each":[100],"arm":[101,113],"(Avelumab+Axitinib":[102],"(AA)":[103],"Sunitinib).":[105],"They":[106],"then":[108],"applied":[109],"opposite":[112],"predictions":[118],"under":[119],"alternative":[120],"therapy.":[121],"Treatment":[122],"summarized":[125],"Kaplan-Meier":[127],"analysis":[128],"restricted":[130],"mean":[131],"times":[133],"(RMST;":[134],"\u03c4":[135],"=":[136,175,182,209,216],"24":[137,353,393],"months)":[138],"based":[139],"follow-up":[142],"Results:":[144],"In":[145,184],"data,":[152],"AA":[153,195,314,318],"demonstrated":[154],"significant":[156],"PFS":[157,163,188,197,322,332,342,352],"benefit":[158,180,282],"compared":[159],"with":[160],"Sunitinib":[161,316,320],"(median":[162,196],"13.6":[164],"vs":[165,199],"8.1":[166],"months;":[167,201],"\u0394RMST":[168,202],"2.68":[169],"months":[170],"[95%":[171,204],"CI:":[172,205],"1.24-4.03],":[173],"p":[174,208],"0.001),":[176],"no":[178],"OS":[179,212,362,372,382,392],"(p":[181,215],"0.11).":[183],"our":[185],"analysis,":[187],"preserved":[189],"robust":[191],"effect":[193],"favoring":[194],"12.4":[198],"8.3":[200],"2.29":[203],"0.72-3.65]":[206],"months,":[207],"0.003),":[210],"while":[211],"did":[213],"not":[214,306],"0.45)":[217],"(Table":[218],"1).":[219],"Application":[220],"cohort":[224],"revealed":[225],"similar":[226],"results.":[227],"Conclusions:":[228],"This":[229],"work":[230],"demonstrates":[231],"how":[232],"approach":[236,274],"can":[237],"be":[238],"used":[239],"estimate":[241],"support":[246],"more":[248],"informed":[249],"transition":[250],"single-arm":[252],"phase":[253,257],"II":[254],"randomized":[256,303],"III":[258],"development.":[259],"By":[260],"enabling":[261],"pre-testing":[262],"new":[264],"drugs":[265,297],"against":[266],"established":[267],"standards":[268],"setting,":[272],"provides":[275],"practical":[277],"means":[278],"evaluate":[280],"expected":[281],"improve":[284],"patient":[285],"selection":[286],"before":[287],"launching":[288],"RCTs.":[289],"Moreover,":[290],"would":[293],"allow":[294],"testing":[296],"rare":[299],"diseases":[300],"where":[301],"study":[304],"is":[305],"feasible.":[307],"Landmark":[308],"probabilities.":[310],"Outcome":[311],"Time":[312],"(months)":[313],"Observed":[315,317],"Counterfactual":[319,321],"6":[323,363],"68.7%":[324],"(63.9-73.9)":[325],"55.8%":[326],"(50.8-61.4)":[327],"68.4%":[328],"(63-73.1)":[329],"57.6%":[330],"(51.7-63.1)":[331],"12":[333,373],"53.5%":[334],"(48.3-59.2)":[335],"39.5%":[336],"(34.4-45.3":[337],"52.0%":[338],"(46-57)":[339],"40.3%":[340],"(34.4-45.7)":[341],"18":[343,383],"43.7%":[344],"(38.3-49.9)":[345],"29.1%":[346,356],"(23.9-35.3)":[347,357],"41.5%":[348],"(35.4-46.4)":[349],"27.8%":[350,360],"(21.6-33.3)":[351,361],"33.4%":[354],"(26.1-42.7)":[355],"29.8%":[358],"(21.1-37.2)":[359],"95.7%":[364,368],"(93.6-97.9)":[365],"92.4%":[366],"(89.7-95.1)":[367],"(93.3-97.8)":[369],"93.6%":[370],"(91.2-96)":[371],"87.3%":[374],"(83.9-90.9)":[375],"83.5%":[376],"(79.7-87.4)":[377],"86.9%":[378],"(82.9-90.2)":[379],"84.4%":[380],"(80.2-88.2)":[381],"78.9%":[384],"(74.5-83.6)":[385],"74.8%":[386],"(70.2-79.7)":[387],"77.3%":[388],"(71.6-81.1)":[389],"75.1%":[390],"(69.3-79.4)":[391],"70.0%":[394],"(64-76.6)":[395],"65.9%":[396],"(59.9-72.5)":[397],"67.5%":[398],"(59.1-73)":[399],"65.7%":[400],"(58.1-70.7)":[401],"AA:":[402],"Avelumab+Axitinib.":[403]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7162640468","counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-05-29T00:00:00"}
